Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$781
|
$736B |
14.0x |
34.9x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$189
|
$399B |
6.9x |
15.1x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$156
|
$389B |
4.3x |
11.9x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 451
|
$329B |
6.7x |
13.4x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 262
|
$287B |
3.7x |
9.3x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 98
|
$268B |
4.8x |
11.7x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£103
|
$245B |
4.2x |
12.2x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$81
|
$229B |
3.5x |
8.2x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$298
|
$209B |
6.1x |
11.2x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$429
|
$190B |
4.4x |
17.5x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$188B |
3.0x |
7.7x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$203
|
$160B |
6.6x |
21.0x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$112
|
$156B |
5.4x |
12.4x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$135B |
2.9x |
10.8x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€83
|
$135B |
2.5x |
8.5x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$460
|
$113B |
9.9x |
35.5x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$96.7B |
2.2x |
6.5x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 243
|
$87.7B |
5.6x |
16.8x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4440
|
$76.3B |
2.4x |
9.3x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$159
|
$75.9B |
8.1x |
18.8x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 7125
|
$74.5B |
9.0x |
18.1x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€26
|
$68.5B |
1.3x |
6.0x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€111
|
$65.0B |
2.6x |
9.1x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$57.2B |
3.7x |
14.9x |
Samsung BioLogics
|
South Korea |
Contract Research & Manufacturing
|
KRW 1038000
|
$54.0B |
14.5x |
35.0x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 560
|
$53.8B |
6.0x |
21.0x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$547
|
$53.5B |
3.9x |
10.8x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 53
|
$46.0B |
11.1x |
41.5x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$547
|
$44.9B |
11.2x |
32.8x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1676
|
$44.3B |
7.1x |
24.8x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$332
|
$41.9B |
16.2x |
233.6x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€42
|
$41.2B |
1.6x |
9.6x |
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$164
|
$41.0B |
2.6x |
11.0x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€169
|
$39.3B |
5.2x |
19.0x |
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 117
|
$37.4B |
7.6x |
33.0x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3223
|
$37.2B |
2.8x |
13.6x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$121
|
$36.5B |
5.5x |
18.7x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 57
|
$35.9B |
2.0x |
6.9x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 178000
|
$30.3B |
10.5x |
34.2x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€467
|
$30.2B |
9.6x |
71.9x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$262
|
$28.1B |
2.1x |
12.3x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 44
|
$27.3B |
2.4x |
11.9x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1209
|
$27.1B |
7.0x |
21.9x |
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 157
|
$26.6B |
6.0x |
-356.1x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$177
|
$26.1B |
2.5x |
12.7x |
Sartorius Stedim Biotech
|
France |
Medical Devices,
Laboratory Services,
Contract Research & Manufacturing
|
€204
|
$25.9B |
7.6x |
26.3x |
Wuxi AppTec
|
China |
Contract Research & Manufacturing,
Laboratory Services
|
CNY 71
|
$25.8B |
4.5x |
12.2x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$24.4B |
1.7x |
5.6x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$133
|
$23.5B |
2.5x |
7.3x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 6772
|
$23.5B |
1.4x |
6.3x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 9
|
$23.0B |
2.3x |
6.5x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$350
|
$22.0B |
7.2x |
19.9x |
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$301
|
$21.6B |
9.4x |
41.9x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1402
|
$21.6B |
1.6x |
8.6x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$162
|
$21.3B |
11.5x |
-83.5x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$36
|
$21.1B |
7.3x |
7.9x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6907
|
$21.0B |
18.4x |
56.9x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 31
|
$20.4B |
11.3x |
30.0x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$98
|
$18.5B |
44.7x |
-20.1x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€9
|
$18.3B |
2.1x |
8.5x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$25
|
$17.9B |
N/A |
-69.3x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$101
|
$17.3B |
4.0x |
15.2x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 86
|
$17.3B |
11.7x |
280.3x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 307
|
$17.1B |
31.0x |
69.4x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 198
|
$16.7B |
10.7x |
31.6x |
Biomerieux
|
France |
Laboratory Services,
Medical Imaging & Diagnostics
|
€119
|
$16.6B |
3.4x |
14.4x |
Eurofins Scientific
|
France |
Laboratory Services,
Contract Research & Manufacturing
|
€61
|
$16.3B |
1.9x |
8.7x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€54
|
$15.5B |
5.3x |
14.2x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$150
|
$15.0B |
1.8x |
9.0x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 375500
|
$14.4B |
109.0x |
278.8x |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$101
|
$14.1B |
5.0x |
16.4x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3368
|
$13.6B |
9.8x |
30.0x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1513
|
$13.1B |
4.0x |
15.6x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 116
|
$12.8B |
31.9x |
-4055.6x |
Wuxi Biologics
|
Hong Kong |
Contract Research & Manufacturing
|
HKD 26
|
$12.8B |
4.6x |
13.3x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1305
|
$12.6B |
3.2x |
12.2x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2439
|
$12.5B |
8.3x |
32.7x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$129
|
$12.3B |
4.9x |
20.2x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 56
|
$12.1B |
2.1x |
15.0x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 6
|
$12.1B |
2.8x |
12.4x |
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$53
|
$11.8B |
4.0x |
30.9x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$46
|
$11.7B |
5.2x |
15.6x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 288
|
$11.7B |
4.1x |
11.3x |
Sonic Healthcare
|
Australia |
Laboratory Services,
Medical Imaging & Diagnostics
|
AUD 27
|
$11.6B |
1.8x |
10.1x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 23
|
$11.5B |
2.0x |
12.3x |
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$23
|
$11.4B |
N/A |
N/A |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1001
|
$11.2B |
4.0x |
13.8x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$15
|
$11.2B |
2.5x |
12.7x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$11.0B |
1.7x |
5.6x |
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$48
|
$10.9B |
5.4x |
14.6x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€148
|
$10.9B |
N/A |
N/A |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$68
|
$10.9B |
2.4x |
16.7x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 8
|
$10.8B |
2.6x |
10.7x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1977
|
$10.7B |
3.9x |
16.3x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€63
|
$10.5B |
5.6x |
17.7x |
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$157
|
$10.5B |
2.6x |
10.9x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2507
|
$10.4B |
3.3x |
8.3x |
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$57
|
$10.4B |
3.5x |
13.5x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 362
|
$10.3B |
38.5x |
-260.6x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 61
|
$10.2B |
N/A |
N/A |